Sixth Street Specialty Lending
TSLX

Sixth Street Specialty Lending (TSLX) news

Recent news

Moody's Ratings assigns a rating to one class of notes issued by Sixth Street CLO 33

Moody's Ratings has assigned a rating to one class of notes issued by Sixth Street CLO 33, as part of its ongoing evaluation of collateralized loan obligations (CLOs) in the market. The rating reflects an assessment of the credit quality, structure, and risk profile of the notes, based on Moody's…

AInvest Wire · Sep 28, 2026

Trisalus Life Sciences shares rise 10.5% after co says received FDA clearance for its TrinaV advance medical device

Trisalus Life Sciences Inc. (NASDAQ: TSLX) reported a 10.5% increase in its stock price following the announcement that the U.S. Food and Drug Administration (FDA) has granted clearance for its TrinaV advanced medical device [1]. The device, designed for the treatment of chronic wounds, is intended…

AInvest Wire · Sep 23, 2026

Trisalus Life Sciences shares rise 18% premarket after co says received FDA clearance for its TrinaV advance medical device

Trisalus Life Sciences Inc. (NASDAQ: TSLX) reported an 18% increase in premarket trading on September 23, 2026, following the company’s announcement that it received clearance from the U.S. Food and Drug Administration (FDA) for its TrinaV advanced medical device . The device is designed for the…

AInvest Wire · Sep 23, 2026

Sixth Street Lending Partners prices offering of $750.0 million 6.500% notes due 2031

Sixth Street Specialty Lending, Inc. (NYSE: TSLX) has announced the pricing of a public offering of $300.0 million in aggregate principal amount of 5.650% notes due 2031, according to a recent press release. The notes are scheduled to mature on August 15, 2031, and may be redeemed in whole or in…

AInvest Wire · Sep 14, 2026

Sixth Street Specialty Lending 2Q NAV/share $16.24, est. $16.29

As of the second quarter of 2026, Sixth Street Specialty Lending Inc. reported a net asset value (NAV) per share of $16.24, with an estimated NAV of $16.29, reflecting the company’s ongoing performance in its specialty finance operations. The company, which focuses on lending to U.S.-domiciled…

AInvest Wire · Aug 4, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.